NMN (Nicotinamide Mononucleotide)
A nucleotide precursor that replenishes cellular NAD+ levels, which decline significantly with age. Among the most-researched longevity compounds with human clinical trial data.
Reviewed & fact-checked by
Dr. Jane Smith, MD, PhDChief Medical Reviewer · Last updated: January 15, 2026
Medical Disclaimer: The information on this page is for educational and research purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Mechanism of Action
NMN (Nicotinamide Mononucleotide) is a direct biosynthetic precursor to NAD+ (Nicotinamide Adenine Dinucleotide), a coenzyme present in virtually every cell. NAD+ is essential for:
- Energy metabolism: Serves as an electron carrier in the mitochondrial electron transport chain
- DNA repair: Required by PARP enzymes for strand break repair
- Sirtuin activation: NAD+ is a required cofactor for SIRT1–7 deacetylases, which regulate aging pathways
- Circadian rhythm: NAD+ biosynthesis is tightly linked to clock gene expression
NAD+ levels decline approximately 50% between ages 40 and 60 in human tissue. NMN supplementation has demonstrated meaningful increases in blood NAD+ metabolites within 2 weeks in human trials. []
Human Clinical Evidence
Key 2023 RCT: A 12-week double-blind randomised controlled trial showed that 250mg/day NMN significantly elevated NAD+ metabolites in whole blood compared to placebo, with improvements in skeletal muscle insulin sensitivity in older adults. []
Bioavailability: Oral NMN is absorbed via the dedicated intestinal transporter Slc12a8 and converted to NAD+ in peripheral tissues. Sublingual and liposomal forms may offer enhanced bioavailability in some protocols, though comparative human data remains limited. []
Forms Comparison
| Form | Bioavailability | Notes | |------|----------------|-------| | Powder (oral) | Standard | Most cost-effective; reference form in clinical trials | | Capsule (oral) | Standard | Convenient and widely available | | Sublingual | Potentially enhanced | Bypasses first-pass metabolism | | Liposomal | Potentially enhanced | Limited comparative human data |
Practical Usage Notes
Start at 250mg/day for 2 weeks before titrating up. Morning timing aligns with circadian biology — the rate-limiting enzyme NAMPT peaks in the morning. For long-term users, co-administering 500mg TMG per 500mg NMN is recommended to maintain methylation balance.
Stacking Interactions
How NMN (Nicotinamide Mononucleotide) interacts with other compounds
The classic Sinclair protocol. Take together in the morning with a fat source for better resveratrol absorption.
500mg TMG per 500mg NMN is a widely used ratio.
If using metformin for longevity, discuss NMN timing with your physician. Some practitioners take them at different times of day.
No significant interaction documented. Both target cellular health via independent pathways.
Safety Profile — Tier A
Well-tolerated — strong human evidence
Contraindications
- ●Active cancer treatment (consult oncologist first)
- ●Pregnancy or breastfeeding (insufficient safety data)
Side Effects
- ●Mild nausea at doses above 1g (take with food)
- ●Mild gastrointestinal discomfort in sensitive individuals